MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharma Industry News From Medical News Today' source. Sat, 26 Jun 2010 07:28:39 +0100 http://www.medworm.com/index.php?rid=3506609&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BMF The Associated Press: The biggest unanswered question in the health overhaul debate remains what the new law will mean for ordinary Americans. "Many experts believe the law falls short on taming costs, and that will force Congress to revisit health care in a few years... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3506609 Tue, 27 Apr 2010 11:00:00 +0100 3506609 http://www.medworm.com/index.php?rid=3506610&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BM2 Scientists have combined chemistry and biology research techniques to explain how certain bacteria grow structures on their surfaces that allow them to simultaneously cause illness and protect themselves from the body's defenses... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3506610 Tue, 27 Apr 2010 08:00:00 +0100 3506610 http://www.medworm.com/index.php?rid=3503822&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BL6 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that Nycomed's U.S. Patent No. 4,758,579 is not invalid... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3503822 Mon, 26 Apr 2010 11:00:00 +0100 3503822 http://www.medworm.com/index.php?rid=3503823&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BJK "The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports. "However, federal officials said that states' losses would be offset by other changes in Medicaid, the federal-state health care program for low-income people... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3503823 Mon, 26 Apr 2010 08:00:00 +0100 3503823 http://www.medworm.com/index.php?rid=3500543&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BJd The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3500543 Sat, 24 Apr 2010 08:00:00 +0100 3500543 http://www.medworm.com/index.php?rid=3496324&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BGp Geithner, Gates Announce New Global Agriculture And Food Security Program In a Wall Street Journal opinion piece, U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3496324 Fri, 23 Apr 2010 11:00:00 +0100 3496324 http://www.medworm.com/index.php?rid=3496325&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BF8 The Association of the British Pharmaceutical Industry (ABPI) was disappointed that the European Court of Justice did not follow the Opinion of Advocate-General Jaaskinen and found that public bodies forming part of a national public health service are not precluded from implementing schemes which offer financial inducements to doctors to switch patients from a named medicine A... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3496325 Fri, 23 Apr 2010 08:00:00 +0100 3496325 http://www.medworm.com/index.php?rid=3496326&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BDt The American College of Physicians (ACP), the largest medical specialty organization and the second-largest physician group in the United States, has signed on to the CMSS Code for Interactions with Companies, released by the Council of Medical Specialty Societies (CMSS)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3496326 Fri, 23 Apr 2010 07:00:00 +0100 3496326 http://www.medworm.com/index.php?rid=3496327&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BCR More than 180 Michigan bioscience leaders gathered at Grand Valley State University in Grand Rapids, MI for MichBio's Annual Meeting and Showcase Wednesday night. In his annual address, Stephen Rapundalo, Ph.D., MichBio president and CEO, said that Michigan's biosciences industry is responsible for over 43,000 direct jobs and 56,000 indirect jobs, with an economic impact of about $10 billion... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3496327 Thu, 22 Apr 2010 12:00:00 +0100 3496327 http://www.medworm.com/index.php?rid=3492555&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BCs The genes in humans and many other species have been surveyed but their operating principles remain rather unknown. Researchers do not know precisely how genes guide development of various human tissues, or what causes developmental disorders. MicroRNA molecules, are recently identified regulatory factors, whose on-going analysis, provide more insight into the matter... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492555 Thu, 22 Apr 2010 11:00:00 +0100 3492555 http://www.medworm.com/index.php?rid=3492558&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BBz Amgen (Nasdaq: AMGN) announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care (BSC) compared to BSC alone... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492558 Thu, 22 Apr 2010 09:00:00 +0100 3492558 http://www.medworm.com/index.php?rid=3492557&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BBs Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced positive results from an in vitro study assessing the efficacy of Restanza™ (cethromycin), its novel oral antibiotic, against 30 strains of Burkholderia pseudomallei, a serious, life-threatening bacterial pathogen. Restanza showed significant in vitro activity against clinical and environmental strains of B... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492557 Thu, 22 Apr 2010 09:00:00 +0100 3492557 http://www.medworm.com/index.php?rid=3492556&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BBm Angiotech Pharmaceuticals, Inc. ( ANPI, TSX: ANP) announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula(TM) PTX(R) clinical trial... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492556 Thu, 22 Apr 2010 09:00:00 +0100 3492556 http://www.medworm.com/index.php?rid=3492559&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BB5 The United States has a potentially substantial competitive advantage in establishing a biobased economy, offering unique opportunities for economic growth, investment and job creation... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492559 Thu, 22 Apr 2010 08:00:00 +0100 3492559 http://www.medworm.com/index.php?rid=3492560&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BB7 Versartis, Inc., an emerging biotechnology company developing novel therapeutics for patients with metabolic diseases, will be represented at the Advancing Protein Therapeutics conference on Wednesday, April 21, by Jeffrey Cleland, Ph.D., Founder and Chief Executive Officer. Dr... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492560 Thu, 22 Apr 2010 06:00:00 +0100 3492560 http://www.medworm.com/index.php?rid=3492561&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3By7 The Wall Street Journal: "Drug companies sharply raised prices last year, ahead of increased rebates they must pay to Medicaid and other expenses tied to the federal health overhaul passed last month. Prices for brand-name pharmaceuticals rose 9.1% last year, the biggest increase in at least a decade, according to pharmacy-benefit manager Express Scripts Inc... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3492561 Wed, 21 Apr 2010 13:00:00 +0100 3492561 http://www.medworm.com/index.php?rid=3489033&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bxt Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3489033 Wed, 21 Apr 2010 10:00:00 +0100 3489033 http://www.medworm.com/index.php?rid=3489032&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bxp Bionovo, Inc. (Nasdaq: BNVI) announced that the US Patent and Trademark Office (USPTO) has issued a patent covering a method of using Bionovo's proprietary drug candidate Bezielle® (BZL101) for the treatment of metastatic breast cancer. The patent issued is Bionovo's second issued patent, with over 70 other patent applications currently pending. Bionovo's US Patent No... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3489032 Wed, 21 Apr 2010 10:00:00 +0100 3489032 http://www.medworm.com/index.php?rid=3489034&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BwX BIO announces the 2010 Leadership Summit: The Role of Biotechnology Innovation in Addressing Climate Change, which will feature senior-level government officials and industry executives sharing developments in industrial and agricultural biotechnology that will make major contributions to adaption to and reduction of climate change emissions and contribute to carbon sequestration... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3489034 Wed, 21 Apr 2010 09:00:00 +0100 3489034 http://www.medworm.com/index.php?rid=3489035&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bwb The Wellcome Trust has announced an injection of 110 million pounds to extend its Seeding Drug Discovery initiative for a further five years. The decision follows an extensive internal review of the programme, whose successes include the completion of a phase I clinical trial of a drug to treat multidrug-resistant bacterial infections... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3489035 Wed, 21 Apr 2010 07:00:00 +0100 3489035 http://www.medworm.com/index.php?rid=3485101&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bv2 Emerging World Pharma Inc. (PINKSHEETS: EWPI) president, Brandon Keks, confirmed today that the company has approved an ongoing investment allocation into European Global Pharma. The first allotment of funding has been set aside as the company completes its due diligence... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3485101 Tue, 20 Apr 2010 12:00:00 +0100 3485101 http://www.medworm.com/index.php?rid=3485102&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BtF What are the best practices to achieve QC Laboratory Excellence? How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems? Leading Pharmaceutical companies will share their first hand experience with transforming the mindset of people, creating the culture of change and continuous improvement in both Quality and Operational Excellence... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3485102 Tue, 20 Apr 2010 11:00:00 +0100 3485102 http://www.medworm.com/index.php?rid=3485103&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BsF Challenges to society, international focus, quality and national-level cooperation are key considerations for the Research Council and the R&D community in planning Norway's new biotechnology research initiative... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3485103 Tue, 20 Apr 2010 09:00:00 +0100 3485103 http://www.medworm.com/index.php?rid=3485104&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bsj Media registration for the 2010 BIO International Convention, the global event for biotechnology, will close on April 23, 2010. Hosted by the Biotechnology Industry Organization (BIO), the event will take place May 3-6, 2010, in Chicago, Ill. at McCormick Place... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3485104 Tue, 20 Apr 2010 08:00:00 +0100 3485104 http://www.medworm.com/index.php?rid=3481934&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Brq Gentel Biosciences, a leader in proteomics discovery tools, today announced the availability of the APiX View™ Detection Kits for ultra-sensitive chromogenic detection of protein microarrays, including reverse phase protein such as SomaPlex™ arrays from Protein Biotechnologies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3481934 Mon, 19 Apr 2010 11:00:00 +0100 3481934 http://www.medworm.com/index.php?rid=3481936&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Br4 Leading-edge technology can drive medical innovation. A company with an idea for a new medical product - such as an artificial organ - needs to assess commercial potential before investing. This can be difficult when the performance of the final product is not known... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3481936 Mon, 19 Apr 2010 10:00:00 +0100 3481936 http://www.medworm.com/index.php?rid=3481935&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Br3 Quantitative risk-benefit assessment has been more and more important for regulatory agencies and pharmaceutical industry for the new-drug - approval process and post-marketing surveillance. Our purposes are to identify and describe quantitative approaches to risk-benefit assessment and to highlight the implications of their differences for the pharmaceutical industry and regulatory agencies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3481935 Mon, 19 Apr 2010 10:00:00 +0100 3481935 http://www.medworm.com/index.php?rid=3480533&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bp7 The Biotechnology Industry Organization (BIO) announced its selection of Senator Robert Menendez (D-NJ) as Legislator of the Year for 2009-2010. Senator Menendez received the award as part of the BIO Legislative Day Fly-In earlier this week... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3480533 Sun, 18 Apr 2010 07:00:00 +0100 3480533 http://www.medworm.com/index.php?rid=3480532&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bnx Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3480532 Sun, 18 Apr 2010 07:00:00 +0100 3480532 http://www.medworm.com/index.php?rid=3478690&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BpH Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) announced that it has completed the construction of an extensive library of full-length, fully human monoclonal antibodies (mAbs). Initial analysis indicates a potential diversity of more than one trillion unique mAbs... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3478690 Sat, 17 Apr 2010 09:00:00 +0100 3478690 http://www.medworm.com/index.php?rid=3474166&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BkC Pharmacyclics, Inc. (Nasdaq: PCYC) announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research (AACR) 2010 Annual Meeting being held April 17-21 in Washington, DC. The oral presentation describes efficacy of the company's first-in-human Btk inhibitor PCI-32765 in a mouse model of pancreatic cancer (Soucek et al)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3474166 Fri, 16 Apr 2010 10:00:00 +0100 3474166 http://www.medworm.com/index.php?rid=3474165&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bkz Kinex Pharmaceuticals (Buffalo, NY) is scheduled to make four presentations at the 101st Annual Meeting of the American Association for Cancer Research (AACR) that will take place at the Walter E. Washington Convention Center in Washington, DC on April 17-21, 2010... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3474165 Fri, 16 Apr 2010 10:00:00 +0100 3474165 http://www.medworm.com/index.php?rid=3470045&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BgM EFPIA, the voice of the research-based pharmaceutical industry in Europe, published the results of their product verification system pilot project. The pilot, held in Sweden between September 2009 and January 2010, successfully demonstrated that a product verification system at the point of dispense, based on a two-dimensional data matrix, is both robust and effective... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3470045 Thu, 15 Apr 2010 10:00:00 +0100 3470045 http://www.medworm.com/index.php?rid=3470044&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bgv QRxPharma (ASX: QRX and OTCQX: QRXPY) announced the successful completion of the first of two pivotal Phase 3 studies for MoxDuo®IR, an immediate-release Dual-Opioid™ pain therapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3470044 Thu, 15 Apr 2010 10:00:00 +0100 3470044 http://www.medworm.com/index.php?rid=3470043&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bgr Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma Inc. announced publication of positive results from their previously reported Phase 1-2 trial of the novel triple-acting oral androgen receptor antagonist MDV3100 in men with progressive, metastatic castration-resistant prostate cancer in the April 15 online version of The Lancet... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3470043 Thu, 15 Apr 2010 10:00:00 +0100 3470043 http://www.medworm.com/index.php?rid=3470046&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bfw The Biosecurity Conference will bring together senior-level government officials, scientists and security professionals to discuss President Obama's strategy to support biotechnology's enormous potential to improve the global quality of life while decreasing the risk of its potential misapplication... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3470046 Thu, 15 Apr 2010 02:00:00 +0100 3470046 http://www.medworm.com/index.php?rid=3470047&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bdj The New York Times has two stories on pharmaceutical industry payments to physicians and experts. In the first, the paper reports that the new federal health care law will require drug companies and medical device makers to disclose payments made to doctors, starting in 2013... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3470047 Wed, 14 Apr 2010 12:00:00 +0100 3470047 http://www.medworm.com/index.php?rid=3465686&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BcK It's illegal for health products with medical formulations to be accepted by the U.S. Food and Drug Administration without tests on animals - a situation that has serious ethical and moral implications. New research in the field of tissue engineering by Prof... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3465686 Wed, 14 Apr 2010 10:00:00 +0100 3465686 http://www.medworm.com/index.php?rid=3465685&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BcC New data presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada, showed that patients with moderate to severe Restless Legs Syndrome (RLS) using rotigotine achieved sustained improvements in symptoms over 5 years of treatment. "Many people with RLS will have spent months or years trying to get a diagnosis and find a treatment that can help them... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3465685 Wed, 14 Apr 2010 10:00:00 +0100 3465685 http://www.medworm.com/index.php?rid=3465684&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BcB Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical-stage cancer biotherapeutics company, announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3465684 Wed, 14 Apr 2010 10:00:00 +0100 3465684 http://www.medworm.com/index.php?rid=3465683&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3Bcz Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3465683 Wed, 14 Apr 2010 10:00:00 +0100 3465683 http://www.medworm.com/index.php?rid=3465687&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3BbZ GEA Pharma Systems presented latest update of ConsiGma™ Continuous Tableting Line (patents pending) to over 120 FDA participants The FDA recognises the value of continuous manufacturing and is working to raise the level of awareness of this technology amongst its review staff... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3465687 Wed, 14 Apr 2010 09:00:00 +0100 3465687 http://www.medworm.com/index.php?rid=3462048&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B8M The San Diego Union-Tribune examines the pharmaceutical industry's growing interest in developing new treatments for what are known as "neglected diseases... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3462048 Tue, 13 Apr 2010 10:00:00 +0100 3462048 http://www.medworm.com/index.php?rid=3462049&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B87 GenVec, Inc. (Nasdaq: GNVC) announced that encouraging clinical and preclinical malaria vaccine data were presented at the Keystone Symposium -- Malaria: New Approaches to Understanding Host-Parasite Interactions taking place April 11-16, 2010 in Copper Mountain, Colorado... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3462049 Tue, 13 Apr 2010 09:00:00 +0100 3462049 http://www.medworm.com/index.php?rid=3458996&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B5J Pfizer Inc. has disclosed its payments to doctors for the first time... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3458996 Mon, 12 Apr 2010 08:00:00 +0100 3458996 http://www.medworm.com/index.php?rid=3458997&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B4w Biomolecules are medicine's jacks-of-all-trades: They are suitable for the diagnosis and treatment of cancer diseases; they are used in the treatment of multiple sclerosis and asthma; they help stimulate the build-up of the body's own immune defenses with flu and polio inoculations... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3458997 Mon, 12 Apr 2010 07:00:00 +0100 3458997 http://www.medworm.com/index.php?rid=3455732&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B5m Eterna Zentaris Inc... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3455732 Sat, 10 Apr 2010 09:00:00 +0100 3455732 http://www.medworm.com/index.php?rid=3455733&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B5g Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced that on Friday April 16th, Eugene C... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3455733 Sat, 10 Apr 2010 08:00:00 +0100 3455733 http://www.medworm.com/index.php?rid=3455734&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B3B Engineering Conferences International (ECI) and the Cell Culture Engineering (CCE) XII Conference are proud to announce Prof. Michael J. Betenbaugh, as the winner of the 2010 Cell Culture Engineering Award. Mike Betenbaugh is Professor of Chemical and Biomolecular Engineering, at Johns Hopkins University, Baltimore, MD, USA... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3455734 Sat, 10 Apr 2010 07:00:00 +0100 3455734 http://www.medworm.com/index.php?rid=3455735&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B4d The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3455735 Sat, 10 Apr 2010 03:00:00 +0100 3455735 http://www.medworm.com/index.php?rid=3451774&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3B3f The pharmaceutical company Pfizer said on Wednesday that it plans to increase the number of clinical trials it's conducting in Singapore by 10 percent as part of an effort "to design drugs for diseases prevalent in the region," Reuters reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3451774 Fri, 09 Apr 2010 11:00:00 +0100 3451774 http://www.medworm.com/index.php?rid=3451775&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zZv The Obama Administration has made substantial progress to avoid retaliatory measures in a long-running "cotton dispute" brought by Brazil against the United States. U.S. Trade Representative Ron Kirk and Secretary of Agriculture Tom Vilsack announced today that the United States and Brazil have agreed upon next steps toward a negotiated settlement with Brazil... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3451775 Fri, 09 Apr 2010 03:00:00 +0100 3451775 http://www.medworm.com/index.php?rid=3446647&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zYc The U.S. Food and Drug Administration today issued warning letters to six U.S. based medical spas and a company in Brazil for making false or misleading statements on their Web sites about drugs they claim will eliminate fat in a procedure called "lipodissolve," or for otherwise misbranding lipodissolve products. The U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3446647 Thu, 08 Apr 2010 10:00:00 +0100 3446647 http://www.medworm.com/index.php?rid=3442334&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zVN Groups In E... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3442334 Wed, 07 Apr 2010 11:00:00 +0100 3442334 http://www.medworm.com/index.php?rid=3442335&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zTN Tragara Pharmaceuticals, Inc. announced the completion of patient enrollment to its APRiCOT-L study, a phase II clinical trial of its oral, once-daily anti-cancer agent, Capoxigem® (apricoxib, TG01), in non-small cell lung cancer (NSCLC)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3442335 Wed, 07 Apr 2010 10:00:00 +0100 3442335 http://www.medworm.com/index.php?rid=3442336&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zT4 Alma Morales Riojas, President and CEO of MANA, recently sent a letter to the Food and Drug Administration (FDA) asking it to accelerate its efforts to remove unapproved drugs from the marketplace and offering to assist the Agency in achieving that goal... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3442336 Wed, 07 Apr 2010 07:00:00 +0100 3442336 http://www.medworm.com/index.php?rid=3439449&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zRJ At the request of the U.S. Food and Drug Administration, U.S. Marshals on March 31 seized a range of consumer products, including creams, capsules, tablets, gum, throat spray, and shampoos from a Haywood, Wis., manufacturer. The U.S. Attorney's Office for the Western District of Wisconsin filed a complaint on March 25 seeking the seizure of the products at Beehive Botanicals Inc... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3439449 Tue, 06 Apr 2010 11:00:00 +0100 3439449 http://www.medworm.com/index.php?rid=3439452&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zRp Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3439452 Tue, 06 Apr 2010 10:00:00 +0100 3439452 http://www.medworm.com/index.php?rid=3439451&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zRk Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3439451 Tue, 06 Apr 2010 10:00:00 +0100 3439451 http://www.medworm.com/index.php?rid=3439450&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zRh Biogen Idec (NASDAQ: BIIB) announced that 38 company-sponsored platform and poster presentations will be presented during the American Academy of Neurology's (AAN) 62nd Annual Meeting in Toronto, April 10 - 17, 2010. The AAN Annual Meeting is the world's largest gathering of neurologists... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3439450 Tue, 06 Apr 2010 10:00:00 +0100 3439450 http://www.medworm.com/index.php?rid=3439453&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zPg BioCenter at Southwestern Medical District offers a springboard to drive biomedical innovation in North Texas to business operations, from earliest stage startups exploring bold new ideas to established companies needing an entire custom-designed floor to bring products to fruition... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3439453 Tue, 06 Apr 2010 08:00:00 +0100 3439453 http://www.medworm.com/index.php?rid=3437030&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zPY This study shows that reducing/abolishing prescription co-payment in Wales had little effect on dispensing rates for prescription drugs. A research team from three Welsh universities (Glamorgan, Cardiff and Bangor) compared General Practice level dispensing rates in Wales with those in another part of the UK where co-payment charges were retained between 2002 and 2008... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3437030 Mon, 05 Apr 2010 09:00:00 +0100 3437030 http://www.medworm.com/index.php?rid=3437031&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zND Prescription drug spending in the United States rose 5.1 percent in 2009, acording to a new report from IMS Health., a data collection company. The Wall Street Journal: Though the rise is higher than the previous two years, "the data pointed to concerns for branded drug makers. The number of prescriptions dispensed for generic drugs rose 5... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3437031 Mon, 05 Apr 2010 07:00:00 +0100 3437031 http://www.medworm.com/index.php?rid=3434363&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zNj YM BioSciences Inc. (NYSE YMI, TSX:YM), announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3434363 Sat, 03 Apr 2010 08:00:00 +0100 3434363 http://www.medworm.com/index.php?rid=3431555&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zLH Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3431555 Fri, 02 Apr 2010 10:00:00 +0100 3431555 http://www.medworm.com/index.php?rid=3431556&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zLk The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives: "We continue to believe that comprehensive health care reform will benefit patients and the future of America... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3431556 Fri, 02 Apr 2010 09:00:00 +0100 3431556 http://www.medworm.com/index.php?rid=3431557&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zLc A novel diagnostic test to rapidly detect neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker that identifies patients at risk for acute kidney injury (AKI), has been accepted for review by the United States Food and Drug Administration. If approved, this would be the first test available for use in the United States for the detection of NGAL... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3431557 Fri, 02 Apr 2010 08:00:00 +0100 3431557 http://www.medworm.com/index.php?rid=3427002&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zJd A Senate briefing will discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3427002 Thu, 01 Apr 2010 08:00:00 +0100 3427002 http://www.medworm.com/index.php?rid=3427001&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zHZ A newly-published clinical study demonstrates that Colcrys® (colchicine, USP), a low-dose oral colchicine, is just as effective as high-dose colchicine in reducing pain associated with early acute gout flare, but with a safety profile statistically indistinguishable from placebo. The study, "High vs... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3427001 Thu, 01 Apr 2010 08:00:00 +0100 3427001 http://www.medworm.com/index.php?rid=3427000&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zHY Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3427000 Thu, 01 Apr 2010 08:00:00 +0100 3427000 http://www.medworm.com/index.php?rid=3422934&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zGN AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3422934 Wed, 31 Mar 2010 11:00:00 +0100 3422934 http://www.medworm.com/index.php?rid=3422936&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zFj Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application (BLA) for KRYSTEXXA™ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3422936 Wed, 31 Mar 2010 08:00:00 +0100 3422936 http://www.medworm.com/index.php?rid=3422935&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zFd Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3422935 Wed, 31 Mar 2010 08:00:00 +0100 3422935 http://www.medworm.com/index.php?rid=3418705&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zCk The Legal Assault on Health Reforms The New York Times No sooner had President Obama signed comprehensive health care reform than the attorneys general of 14 states scurried to the federal courts to challenge the law. ... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3418705 Tue, 30 Mar 2010 10:00:00 +0100 3418705 http://www.medworm.com/index.php?rid=3418708&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zBF GlaxoSmithKline (NYSE: GSK) announced that it has re-submitted the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration (FDA). The re-submission provides an update to the initial application in 2009... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3418708 Tue, 30 Mar 2010 08:00:00 +0100 3418708 http://www.medworm.com/index.php?rid=3418707&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zBx Cephalon, Inc. (Nasdaq: CEPH) announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3418707 Tue, 30 Mar 2010 08:00:00 +0100 3418707 http://www.medworm.com/index.php?rid=3418706&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zBw GenVec, Inc. (Nasdaq: GNVC) announced that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3418706 Tue, 30 Mar 2010 08:00:00 +0100 3418706 http://www.medworm.com/index.php?rid=3413677&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zzD Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization (BIO) thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3413677 Mon, 29 Mar 2010 10:00:00 +0100 3413677 http://www.medworm.com/index.php?rid=3412168&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zwH The Biotechnology Industry Organization (BIO) today announces that Wednesday, May 5th has been named International Day, and will include a special programming track on Global Biotechnology Issues. International Case Studies will be presented throughout the week on topics such as breakthroughs in molecular diagnostics, biomarkers, dementia and Alzheimer's, and translational R&D... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3412168 Sun, 28 Mar 2010 07:00:00 +0100 3412168 http://www.medworm.com/index.php?rid=3410017&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zxT Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) i... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3410017 Sat, 27 Mar 2010 08:00:00 +0100 3410017 http://www.medworm.com/index.php?rid=3410016&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zxR VIVUS, Inc. (Nasdaq: VVUS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is tentatively scheduled to review the Company's New Drug Application (NDA) for Qnexa® for the treatment of obesity on July 15, 2010... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3410016 Sat, 27 Mar 2010 08:00:00 +0100 3410016 http://www.medworm.com/index.php?rid=3406655&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ztS The Prime Minister's announcement that he is minded to appoint a Minister for Life Sciences in the next Parliament is to be applauded and is welcomed by the UK's four life sciences trade associations - the Association for the British Healthcare Industry, the Association for the British Pharmaceutical Industry, the BioIndustry Association and the British In Vitro Diagnostics Association... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3406655 Fri, 26 Mar 2010 10:00:00 +0100 3406655 http://www.medworm.com/index.php?rid=3406656&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zt3 The economic recession has generated a clear and powerful sense of engagement between workers and bosses, with a quarter of employees in the pharmaceutical sector surveyed saying they are more loyal to their employer - as a direct result of the economic downturn - according to the latest survey from global workforce solutions leader Kelly Services... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3406656 Fri, 26 Mar 2010 08:00:00 +0100 3406656 http://www.medworm.com/index.php?rid=3406657&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zs8 SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) announced the European approval of ondansetron RapidFilm™, co-developed by APR Applied Pharma Research s.a. ("APR"), and Labtec GmbH and licensed to BioAlliance Pharma s.a. for European Union ("EU") countries. BioAlliance was granted approval under the EU decentralized procedure in 16 major EU countries... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3406657 Thu, 25 Mar 2010 18:00:00 +0100 3406657 http://www.medworm.com/index.php?rid=3401541&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zqQ Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that it has achieved last-patient-out in its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW). Accordingly, all patients enrolled in the study have completed the prescribed study procedures, and Helix will now proceed to closing of the database and analysis of the results... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3401541 Thu, 25 Mar 2010 10:00:00 +0100 3401541 http://www.medworm.com/index.php?rid=3397314&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zmJ Kaiser Health News: "Most health industry sectors are winners - some bigger than others -- under sweeping health care legislation that will expand coverage to 32 million uninsured Americans over the next decade, analysts say... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3397314 Wed, 24 Mar 2010 10:00:00 +0100 3397314 http://www.medworm.com/index.php?rid=3397315&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zkv Novozymes Biopharma, part of Novozymes A/S announces new data which demonstrates extended shelf life of protein drug products using Recombumin, recombinant human albumin. The data, presented for the first time at a recent protein-focused industry event, reveals the potential for Recombumin to reduce product loss by preventing the physical and chemical degradation of protein drugs... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3397315 Wed, 24 Mar 2010 08:00:00 +0100 3397315 http://www.medworm.com/index.php?rid=3397316&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zkk The Biotechnology Study Center of NYU School of Medicine will hold its annual awards symposium on April 5, 2010, to honor three outstanding leaders in biomedical research... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3397316 Wed, 24 Mar 2010 07:00:00 +0100 3397316 http://www.medworm.com/index.php?rid=3397317&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zjT Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement after passage of "The Patient Protection and Affordable Care Act of 2009" by the U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3397317 Wed, 24 Mar 2010 05:00:00 +0100 3397317 http://www.medworm.com/index.php?rid=3392963&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zgQ Before you swallow a tablet, or put it into a glass of water to dissolve, do you ever stop and think about how it actually works in your body and how quickly and effectively it can deliver the drug to where it is needed? The answer will probably be no... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3392963 Tue, 23 Mar 2010 08:00:00 +0100 3392963 http://www.medworm.com/index.php?rid=3392964&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zfW Theranostics is an emerging field in clinical diagnostics, focussing on developing specific analysis to predict the most suitable drug for a patient along with assessing the efficacy of the drug. It uses molecular assays to determine the optimum dose of drugs for a patient, paving the way for personalised medicine... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3392964 Mon, 22 Mar 2010 13:00:00 +0100 3392964 http://www.medworm.com/index.php?rid=3388214&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3zfL Production of chemicals and plastics from renewable resources can reduce reliance on petroleum, cut greenhouse gas emissions, and create jobs... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3388214 Mon, 22 Mar 2010 12:00:00 +0100 3388214 http://www.medworm.com/index.php?rid=3381147&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z9s BioTrends is pleased to announce the publication of a new syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3381147 Fri, 19 Mar 2010 10:00:00 +0100 3381147 http://www.medworm.com/index.php?rid=3381148&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z8p As drug makers around the world continue to navigate the complex and ever-changing landscape referred to as the New Health , many companies are flocking to Asia-Pacific for better access to patients, improved operational efficiencies and increasingly, pharmaceutical innovation. In a new report released today, Ferzaan Engineer, Ph.D... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3381148 Fri, 19 Mar 2010 07:00:00 +0100 3381148 http://www.medworm.com/index.php?rid=3376413&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z75 USA Today: "The cost of cancer treatment is 'skyrocketing' - both for individual patients and the nation, a new analysis shows. From 1990 to 2008, spending on cancer care soared to more than $90 billion from $27 billion... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376413 Thu, 18 Mar 2010 12:00:00 +0100 3376413 http://www.medworm.com/index.php?rid=3376412&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z74 Growing markets for pharmaceuticals in China, Brazil, Russia and India are outpacing national markets in Europe and the U.S., but major drugmakers have been slow to expand in these markets and may lose opportunities, a new study finds, The New York Times reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376412 Thu, 18 Mar 2010 12:00:00 +0100 3376412 http://www.medworm.com/index.php?rid=3376415&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z6B InterMune, Inc. (Nasdaq: ITMN) announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376415 Thu, 18 Mar 2010 11:00:00 +0100 3376415 http://www.medworm.com/index.php?rid=3376414&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z6x Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) announced that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376414 Thu, 18 Mar 2010 11:00:00 +0100 3376414 http://www.medworm.com/index.php?rid=3372368&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z4j The Healthcare Distribution Management Association (HDMA) presented its first Distribution Management Award to AmerisourceBergen Packaging Group (ABPG) and Pfizer Pharmaceuticals for its Toviaz™ Physician Sample Package Optimization project... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3372368 Wed, 17 Mar 2010 12:00:00 +0100 3372368 http://www.medworm.com/index.php?rid=3372367&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z49 The advocacy group Medecins Sans Frontieres (MSF) recently warned that free-trade negotiations between the EU and India could limit access to "affordable generic drugs" for people in India and the rest of the developing world, Reuters reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3372367 Wed, 17 Mar 2010 12:00:00 +0100 3372367 http://www.medworm.com/index.php?rid=3368448&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yYc David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce for Intellectual Property, will be a featured speaker at the Intellectual Property Super Session taking place during the 2010 BIO International Convention... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3368448 Tue, 16 Mar 2010 11:00:00 +0100 3368448 http://www.medworm.com/index.php?rid=3365077&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yVY Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the first commercial production of SONOVA™ 400 High GLA Safflower Oil... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3365077 Mon, 15 Mar 2010 12:00:00 +0100 3365077 http://www.medworm.com/index.php?rid=3363396&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ySR As part of the final phase of its transparency initiative, the U.S. Food and Drug Administration is seeking comment from the public and other interested stakeholders on how the agency can increase transparency in its interactions with regulated industry. Posted in the March 12, 2010, Federal Register, the request for electronic or written comments has a deadline of April 12, 2010... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3363396 Sun, 14 Mar 2010 08:00:00 +0100 3363396 http://www.medworm.com/index.php?rid=3361259&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yRv A growing volume of global drug development and commercialization activity during the past decade has dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies, according to a study recently completed by the Tufts Center for the Study of Drug Development... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3361259 Fri, 12 Mar 2010 18:00:00 +0100 3361259 http://www.medworm.com/index.php?rid=3356835&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yQJ The Pharmaceutical Research and Manufacturers of America spent $6.3 million lobbying Congress and other government arms on health care in the fourth quarter of 2009, The Associated Press reports. PhRMA "spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period. The group's members include drug giants Pfizer Inc., Merck & Co... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356835 Fri, 12 Mar 2010 11:00:00 +0100 3356835 http://www.medworm.com/index.php?rid=3356837&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yQ5 Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356837 Fri, 12 Mar 2010 10:00:00 +0100 3356837 http://www.medworm.com/index.php?rid=3356836&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPZ On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) -- including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees -- discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356836 Fri, 12 Mar 2010 10:00:00 +0100 3356836 http://www.medworm.com/index.php?rid=3356839&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPH Federal tax policies should incentivize commercial deployment of advanced industrial biotechnologies, which can create jobs, reduce reliance on petroleum, and achieve greenhouse gas reductions... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356839 Fri, 12 Mar 2010 09:00:00 +0100 3356839 http://www.medworm.com/index.php?rid=3356838&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPy A package of tough new actions to ensure that NHS patients can get the medicines they need was agreed at a summit to discuss concerns about current difficulties with the supply of medicines, hosted by Health Secretary Andy Burnham and Health Minister Mike O'Brien yesterday... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356838 Fri, 12 Mar 2010 09:00:00 +0100 3356838 http://www.medworm.com/index.php?rid=3356840&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yNx Drug maker GlaxoSmithKline (GSK) "plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations," Bloomberg/BusinessWeek reports. "Our strategy is to grow our business in middle-income countries by increasing the volume of products we sell," GSK Chief Executive Andrew Witty said by e-mail, according to the news service... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356840 Thu, 11 Mar 2010 14:00:00 +0100 3356840 http://www.medworm.com/index.php?rid=3356841&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yNd The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356841 Thu, 11 Mar 2010 13:00:00 +0100 3356841 http://www.medworm.com/index.php?rid=3352444&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yMB A Perspective piece in the New England Journal of Medicine calls for change in the way researchers and pharmaceutical companies collect and report adverse symptom information in clinical trials submitted to the Food and Drug Administration (FDA), and how the FDA represents this information on drug labels... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3352444 Thu, 11 Mar 2010 11:00:00 +0100 3352444 http://www.medworm.com/index.php?rid=3352445&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yMf Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), announced that the U.S. Food and Drug Administration (FDA) recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3352445 Thu, 11 Mar 2010 10:00:00 +0100 3352445 http://www.medworm.com/index.php?rid=3348731&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yJ9 For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348731 Wed, 10 Mar 2010 10:00:00 +0100 3348731 http://www.medworm.com/index.php?rid=3348732&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yHT An analysis by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348732 Wed, 10 Mar 2010 09:00:00 +0100 3348732 http://www.medworm.com/index.php?rid=3348733&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yHw Medtronic, Inc., (NYSE: MDT), announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's Distinguished Achievement Award. As part of the award, the plenary lecture he delivered to the organization was published in the March 2010 edition of the Annals of Biomedical Engineering... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348733 Wed, 10 Mar 2010 08:00:00 +0100 3348733 http://www.medworm.com/index.php?rid=3345041&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yFj The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms. The novel protein named haditoxin has been described in the prestigious Journal of Biological Chemistry (March 12, 2010)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345041 Tue, 09 Mar 2010 10:00:00 +0100 3345041 http://www.medworm.com/index.php?rid=3345042&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yDP Nektar Therapeutics (Nasdaq: NKTR) announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345042 Tue, 09 Mar 2010 09:00:00 +0100 3345042 http://www.medworm.com/index.php?rid=3345043&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yDc While clinical laboratories are vital to the diagnostic industry, they are facing multiple challenges that will require increased automation in order for them to remain competitive... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345043 Mon, 08 Mar 2010 13:00:00 +0100 3345043 http://www.medworm.com/index.php?rid=3337127&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yB4 InterMune, Inc. (Nasdaq: ITMN) announced that the U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337127 Sat, 06 Mar 2010 09:00:00 +0100 3337127 http://www.medworm.com/index.php?rid=3337126&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yB2 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337126 Sat, 06 Mar 2010 09:00:00 +0100 3337126 http://www.medworm.com/index.php?rid=3337128&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxJ The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications - Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337128 Sat, 06 Mar 2010 02:00:00 +0100 3337128 http://www.medworm.com/index.php?rid=3337129&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxy The Biotechnology Industry Organization announced that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago May 3-6 and is expected to draw 15,000 to 17,000 industry leaders from 48 states and 60 countries... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337129 Fri, 05 Mar 2010 19:00:00 +0100 3337129 http://www.medworm.com/index.php?rid=3333531&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxp Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333531 Fri, 05 Mar 2010 12:00:00 +0100 3333531 http://www.medworm.com/index.php?rid=3333530&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxn Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that results from a clinical trial of Caldolor® (ibuprofen) Injection will be presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans, Louisiana... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333530 Fri, 05 Mar 2010 12:00:00 +0100 3333530 http://www.medworm.com/index.php?rid=3333532&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yv2 Medtronic, Inc. (NYSE: MDT) announced that it has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing technology and in using it both to grow their own business and transform how we live... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333532 Thu, 04 Mar 2010 22:00:00 +0100 3333532 http://www.medworm.com/index.php?rid=3329422&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ytd Dendreon Corporation (Nasdaq: DNDN) announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329422 Thu, 04 Mar 2010 13:00:00 +0100 3329422 http://www.medworm.com/index.php?rid=3329423&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yt5 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329423 Thu, 04 Mar 2010 12:00:00 +0100 3329423 http://www.medworm.com/index.php?rid=3329424&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ysF Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a number of additional benefits. IIT management, however, can be challenging. Data collected by business intelligence firm Cutting Edge Information show that 75% of surveyed companies have some form of dedicated IIT management group in place... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329424 Thu, 04 Mar 2010 11:00:00 +0100 3329424 http://www.medworm.com/index.php?rid=3325281&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yrm Complete Medical Group (CMG) has today launched a new division, Complete Digital, at the eyeforpharma 5th Annual Pharma eMarketing Summit. Complete Digital, led by digital industry expert Kay Wesley, is gold sponsor of the event, aimed at engaging physicians and consumers with innovative eMarketing and social media strategies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325281 Wed, 03 Mar 2010 12:00:00 +0100 3325281 http://www.medworm.com/index.php?rid=3325280&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypy Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325280 Wed, 03 Mar 2010 12:00:00 +0100 3325280 http://www.medworm.com/index.php?rid=3325279&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypw InterMune, Inc. (Nasdaq: ITMN) announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the European Union (EU). Currently, there are no EMA-approved treatments for IPF in the EU... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325279 Wed, 03 Mar 2010 12:00:00 +0100 3325279 http://www.medworm.com/index.php?rid=3325278&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypr Abbott (NYSE: ABT) and Enanta Pharmaceuticals announced the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and polymerase inhibitors ABT-333 and ABT-072 currently being developed exclusively by Abbott... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325278 Wed, 03 Mar 2010 12:00:00 +0100 3325278 http://www.medworm.com/index.php?rid=3325277&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypq Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that data from a recent study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating pain and fever in hospitalized burn patients will be presented at the 42nd Annual Meeting of the American Burn Association in Boston... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325277 Wed, 03 Mar 2010 12:00:00 +0100 3325277 http://www.medworm.com/index.php?rid=3325282&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yqh Politico: "In the absence of clear next steps, outside groups have stepped in to beat the drum, keeping time while the leadership meets behind closed doors to write the next movement. ... Progressive advocacy groups like Health Care for America Now and Families USA are organizing supporters and protests across the country, reminding Americans and lawmakers why inaction is unacceptable... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325282 Wed, 03 Mar 2010 11:00:00 +0100 3325282 http://www.medworm.com/index.php?rid=3325284&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ynR The Biotechnology Industry Organization announces that representatives of biotech and pharmaceutical companies, academic research institutions and licensing professionals, as well as investors attending the BIO International Convention Business Forum can now begin to request One-on-One business development meetings through BIO's proprietary partnering system... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325284 Wed, 03 Mar 2010 10:00:00 +0100 3325284 http://www.medworm.com/index.php?rid=3325283&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ynp Starting in 2010, Springer will publish the European Journal of Drug Metabolism and Pharmacokinetics. All aspects of drug delivery and bioavailability are covered in the journal, which was previously published by the Swiss publisher Médecine & Hygiène... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325283 Wed, 03 Mar 2010 10:00:00 +0100 3325283 http://www.medworm.com/index.php?rid=3325285&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ymc Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in observance of Rare Disease Day 2010. This event recognizes the profound need for more medical research and the unique partnership that exists between rare disease patients and researchers... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325285 Wed, 03 Mar 2010 06:00:00 +0100 3325285 http://www.medworm.com/index.php?rid=3325286&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ym9 The 2010 BIO International Convention will feature the first-ever BIOPark, a hub focused on fostering networking and collaboration among academics, licensing professionals, incubator services, and early-stage companies, announced the Biotechnology Industry Organization (BIO) today... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325286 Wed, 03 Mar 2010 05:00:00 +0100 3325286 http://www.medworm.com/index.php?rid=3320325&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yjz Three top California Medicaid officials in charge of pharmacy issues failed to disclose trips paid for by drug-industry funded business groups, California Watch/San Francisco Chronicle reports. Officials who are directly involved in setting drug policy and negotiating payments took about 12 trips paid for by these nonprofit business groups... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3320325 Tue, 02 Mar 2010 09:00:00 +0100 3320325 http://www.medworm.com/index.php?rid=3320326&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yhd Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to an article in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3320326 Mon, 01 Mar 2010 17:00:00 +0100 3320326 http://www.medworm.com/index.php?rid=3313491&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfN Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with advanced ovarian cancer lived without their disease worsening (progression-free survival or PFS) compared to chemotherapy alone... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313491 Sat, 27 Feb 2010 10:00:00 +0100 3313491 http://www.medworm.com/index.php?rid=3313490&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfM Gilead Sciences, Inc. (Nasdaq:GILD) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston(R)(aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313490 Sat, 27 Feb 2010 10:00:00 +0100 3313490 http://www.medworm.com/index.php?rid=3313489&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfL Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA). Bystolic is currently approved in the US for the treatment of hypertension... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313489 Sat, 27 Feb 2010 10:00:00 +0100 3313489 http://www.medworm.com/index.php?rid=3313492&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfm Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313492 Sat, 27 Feb 2010 09:00:00 +0100 3313492 http://www.medworm.com/index.php?rid=3313493&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybY Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening. Ion channels are proteins in cell membranes that play a central role in generating and transmitting cardiac and neural signals... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313493 Sat, 27 Feb 2010 08:00:00 +0100 3313493 http://www.medworm.com/index.php?rid=3309583&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybL Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3309583 Fri, 26 Feb 2010 12:00:00 +0100 3309583 http://www.medworm.com/index.php?rid=3309582&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybK Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine™ (talaporfin sodium) for treatment of solid tumors. LSO's global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3309582 Fri, 26 Feb 2010 12:00:00 +0100 3309582 http://www.medworm.com/index.php?rid=3304783&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y6X Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3304783 Thu, 25 Feb 2010 11:00:00 +0100 3304783 http://www.medworm.com/index.php?rid=3304784&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y5X The third annual George Washington Carver Award will recognize significant contributions by an individual to the field of industrial biotechnology, including applications in biological engineering, environmental science, biorefining and biobased products... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3304784 Thu, 25 Feb 2010 09:00:00 +0100 3304784